Skip to content

The Effect of Pharmacological Treatment for ADHD on Physical Performance in Male Adolescents

The Effect of Pharmacological Treatment for ADHD on Physical Performance in Male Adolescents

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05517785
Enrollment
70
Registered
2022-08-26
Start date
2023-02-01
Completion date
2024-06-30
Last updated
2023-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD

Brief summary

The aim of this study is to evaluate the effects of stimulant ADHD pharmacotherapy on motor performance in male adolescents.

Detailed description

This study is designed as a single-center, crossover, randomized study. 70 high-school aged males aged between 15 and 18 years with a diagnosis of ADHD who are being treated pharmacologically using stimulants (such as Ritalin, Concerta, Vyvanse etc) will be recruited. The study will investigate motor performance using several motor function tests both with and without the influence of stimulant ADHD medications. Participants will be assessed on two separate occasions, both sessions will occur during the morning in their regular school environment. During the sessions, participants will be randomized, 50% will be assessed one hour after taking their usual stimulant ADHD medication and the other 50% will be asked to postpone taking their usual stimulant ADHD medication until the session is finished. During the two separate sessions, all participants will be asked to perform the following motor tests: plank, single leg stance test, standing long jump test (broad jump), 4 x 10 agility tests and 20 m shuttle run tests (beeps).

Interventions

OTHERMotor performance tests

Performance of 5 motor tests: plank, single leg stance test, standing long jump test (broad jump), 4 x 10 agility test and 20 m shuttle run tests (beeps), after taking ADHD drug or not taking the drug before motor tests performance

Sponsors

Wingate Institute
CollaboratorOTHER
Loewenstein Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
15 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* High school male students * Diagnosis of ADHD * Treatment with prescribed stimulants for ADHD (e.g. Concerta, Ritalin, Phenidin, Focalin etc.).

Exclusion criteria

* Students with concomitant chronic disease (including asthma, cardiac, motor, neurological and gastrointestinal disturbances) * History of acute illness in the previous two weeks * Any injuries that would inhibit the ability to exercise or play sport * Students unable to obtain parental/guardian consent * Students unwilling to participate

Design outcomes

Primary

MeasureTime frameDescription
Motor tests5 minutesPlank
AAC-Q questionnaire10 minutesAdolescents and Adults Coordination Questionnaire

Secondary

MeasureTime frameDescription
Heart rate at rest5 minutesHeart rate will be measured in a sitting position
Blood pressure at rest5 minutesBlood pressure will be measured in a sitting position

Countries

Israel

Contacts

Primary ContactAviva Mimouni-Bloch, Prof
abloch@clalit.org.il7709085
Backup ContactSharon Tsuk, Ph.D
sharontsuk1@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026